Elisa Scarselli

Company: Nouscom Srl

Seminars:

Nouscom Genetic Vaccine Encoding Shared Neoantigens to Treat Tumors with MicroSatellite Instability (MSI) 3:00 pm

Large neoantigen payload is ensured by Nouscom genetic vaccination platform GAd/MVA heterologous prime/boost results in induction of CD8 T cells in preclinical models and cancer patients T cells trafficking and expansion in the tumor is the key driver of treatment efficacyRead more

day: Day One